Liquid Biopsy Platform for Early Colorectal Cancer Detection at AACR 2023Rapid blood test sensitive to advanced adenomas could improve patient prognosis and ultimately reduce mortality Dxcover Limited, a...
Dxcover Raises $11.9m in Series A and Grant Funding to Accelerate Liquid Biopsy to MarketEnables CE Marking of blood test for brain cancer and advances colorectal cancer development Glasgow, Scotland, February 1, 2023 Dxcover...
Dxcover Secures Grant from the European Innovation Council Grant enables pivotal multi-centre study for CE Marking of Dxcover Brain Cancer Liquid Biopsy Dxcover Limited, a clinical stage...